Manifestations of the gastrointestinal tract in systemic rheumatic diseases: A narrative review
https://doi.org/10.47360/1995-4484-2022-578-586
Abstract
Gastrointestinal disorders are important place among the visceral manifestations of systemic autoimmune and immunoinflammatory rheumatic diseases (RD). Pathology of the esophagus, stomach, small and large intestine can vary from moderate functional disorders to the development of severe chronic inflammation with metaplasia and dysplasia of the mucous membrane, the formation of multiple erosions, hemorrhages and deep ulcers. Complications of gastrointestinal pathology in RD, such as bleeding, perforations and strictures, can cause death. This review examines the main clinical manifestations, possibilities of diagnosis and treatment of gastrointestinal lesions in systemic scleroderma, idiopathic inflammatory myopathies, systemic vasculitis, Sjogren’s syndrome and disease, as well as systemic lupus erythematosus.
About the Authors
E. V. MorozRussian Federation
105094, Moscow, Gospitalnaya square, 3A
T. V. Popkova
Russian Federation
115522, Moscow, Kashirskoye Highway, 34A
A. E. Moroz
Russian Federation
115522, Moscow, Kashirskoye Highway, 34A
References
1. Nasonov EL (ed.). Rheumatology. Russian clinical recommendations. Moscow:GEOTAR-Media;2020 (In Russ.)].
2. Kröner PT, Tolaymat OA, Bowman AW, Abril A, Lacy BE. Gastrointestinal manifestations of rheumatological diseases. Am J Gastroenterol. 2019;114(9):1441-1454. doi: 10.14309/ajg.0000000000000260
3. Kalkan EA, Kalkan Ç, Barutcu S, Küçükşahin O, Güçbey Ö, Köseoğlu T, et al. Prevalence and determinants of gastrointestinal manifestations in patients with selected rheumatologic diseases. Turk J Gastroenterol. 2022;33(7):576-586. doi: 10.5152/tjg.2022.21780
4. Hijos-Mallada G, Sostres C, Gomollón F. NSAIDs, gastrointestinal toxicity and inflammatory bowel disease. Gastroenterol Hepatol. 2022;45(3):215-222. doi: 10.1016/j.gastrohep.2021.06.003
5. Kate V, Sureshkumar S, Gurushankari B, Kalayarasan R. Acute upper non-variceal and lower gastrointestinal bleeding. J Gastrointest Surg. 2022;26(4):932-949. doi: 10.1007/s11605-022-05258-4
6. El Osta L, El Osta N, El Osta H. Benefits and potential risks of bisphosphonate therapy: A narrative review. J Med Liban. 2016;64(4):228-237. doi: 10.12816/0033797
7. Jagpal A, Curtis JR. Gastrointestinal perforations with biologics in patients with rheumatoid arthritis: Implications for clinicians. Drug Saf. 2018;41(6):545-553. doi: 10.1007/s40264-018-0639-1
8. Oncel S, Basson MD. Gut homeostasis, injury, and healing: New therapeutic targets. World J Gastroenterol. 2022;28(17):1725-1750. doi: 10.3748/wjg.v28.i17.1725
9. Christovich A, Luo XM. Gut microbiota, leaky gut, and autoimmune diseases. Front Immunol. 2022;13:946248. doi: 10.3389/fimmu.2022.946248
10. Jonaitis L, Pellicano R, Kupcinskas L. Helicobacter pylori and nonmalignant upper gastrointestinal diseases. Helicobacter. 2018;23(Suppl 1):e12522. doi: 10.1111/hel.12522
11. Karateev AE, Tsurgan AV, Moroz EV. Helicobacter pylori in patients with rheumatic diseases: The incidence of infection and evaluation of the effectiveness of the alternative scheme of eradication therapy. Russian Medical Journal. 2017;17:1220-1224 (In Russ.)].
12. Craig E, Cappelli LC. Gastrointestinal and hepatic disease in rheumatoid arthritis. Rheum Dis Clin North Am. 2018;44(1): 89-111. doi: 10.1016/j.rdc.2017.09.005
13. Chetty R, Serra S. A pragmatic approach to vasculitis in the gastrointestinal tract. J Clin Pathol. 2017;70(6):470-475. doi: 10.1136/jclinpath-2016-204308
14. Nakane S, Mukaino A, Ihara E, Ogawa Y. Autoimmune gastrointestinal dysmotility: The interface between clinical immunology and neurogastroenterology. Immunol Med. 2021;44(2):74-85. doi: 10.1080/25785826.2020.1797319
15. Ahuja NK, Clarke JO. Scleroderma and the esophagus. Gastroenterol Clin North Am. 2021;50(4):905-918. doi: 10.1016/j.gtc.2021.08.005
16. McMahan ZH, Hummers LK. Gastrointestinal involvement in systemic sclerosis: Diagnosis and management. Curr Opin Rheumatol. 2018;30(6):533-540. doi: 10.1097/BOR.0000000000000545
17. Cheah JX, Khanna D, McMahan ZH. Management of scleroderma gastrointestinal disease: Lights and shadows. J Scleroderma Relat Disord. 2022;7(2):85-97. doi: 10.1177/23971983221086343
18. Karateev AE, Movsisyan MS, Radenska-Lopovok SG, Ananyeva LP. The real prevalence of erosive esophagitis and Barrett’s esophagus in systemic scleroderma: Data from 12-months prospective study. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2012;54(5):51-55 (In Russ.)].
19. Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021;7(1):86. doi: 10.1038/s41572-021-00321-x
20. Kovaleva NV, Khelkovskaya-Sergeeva AN, Ushakova MA. Radiologic examination of pharynx for oropharyngeal dysphagia in a patient with dermatomyositis (clinical observation). Medical Visualization. 2021;25(2):116-123 (In Russ.)]. doi: 10.24835/1607-0763-934
21. Gadiparthi C, Hans A, Potts K, Ismail MK. Gastrointestinal and hepatic disease in the inflammatory myopathies. Rheum Dis Clin North Am. 2018;44(1):113-129. doi: 10.1016/j.rdc.2017.09.006
22. Ebert EC. Review article: The gastrointestinal complications of myositis. Aliment Pharmacol Ther. 2010;31(3):359-365. doi: 10.1111/j.1365-2036.2009.04190.x
23. Pillebout E, Sunderkötter C. IgA vasculitis. Semin Immunopathol. 2021;43(5):729-738. doi: 10.1007/s00281-021-00874-9
24. Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch – Shönlein purpura) in adults: Diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14(7):579- 585. doi: 10.1016/j.autrev.2015.02.003
25. Miniter U, Bae-Harboe YS, Powers JG, Campbell SM, Goldberg LJ. Fatal Henoch – Schonlein purpura in an adult related to bowel perforation: Report and review of the literature. Dermatol Online J. 2012;18(10):9.
26. Tobino K, Shimizu Y, Miura S, Takeda T, Tomino Y. Severe erosive lesions in the digestive tract of patients with Henoch – Schönlein Purpura (HSP) and its impact on prognosis – Presentation of two cases and statistical review of adult-onset Japanese HSP. Clin Nephrol. 2011;75(Suppl 1):47-55.
27. Nakamura S, Hisamatsu T, Kikuchi J, Adachi M, Yamagishi Y, Imaeda H, et al. A case of IgA-related enteropathy complicated with gastrointestinal bleeding and progressive IgA nephropathy: A possible variant Henoch – Schönlein purpura? Intern Med. 2010;49(16):1755-1761. doi: 10.2169/internalmedicine.49.3678
28. Kötter I, Lötscher F. Behçet’s syndrome apart from the triple symptom complex: Vascular, neurologic, gastrointestinal, and musculoskeletal manifestations. A mini review. Front Med (Lausanne). 2021;8:639758. doi: 10.3389/fmed.2021.639758
29. Nguyen A, Upadhyay S, Javaid MA, Qureshi AM, Haseeb S, Javed N, et al. Behcet’s disease: An in-depth review about pathogenesis, gastrointestinal manifestations, and management. Inflamm Intest Dis. 2021;6(4):175-185. doi: 10.1159/000520696
30. Goloeva RG, Alekberova ZS, Lisitsyina TA, Stepanova EA, Orlova LP. Intestinal manifestations of Behçet’s disease. Terapevticheskii arkhiv. 2019;91(5): 111-119 (In Russ.)]. doi: 10.26442/00403660.2019.05.000247
31. Springer JM, Byram K. Polyarteritis nodosa: An evolving primary systemic vasculitis. Postgrad Med. 2022 Jun 22:1-8. doi: 10.1080/00325481.2022.2088940
32. Soowamber M, Weizman AV, Pagnoux C. Gastrointestinal aspects of vasculitides. Nat Rev Gastroenterol Hepatol. 2017;14(3):185-194. doi: 10.1038/nrgastro.2016.179
33. Ebert EC, Hagspiel KD, Nagar M, Schlesinger N. Gastrointestinal involvement in polyarteritis nodosa. Clin Gastroenterol Hepatol. 2008;6(9):960-966. doi: 10.1016/j.cgh.2008.04.004
34. Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, et al. Churg – Strauss syndrome. Autoimmun Rev. 2015; 14(4):341-348. doi: 10.1016/j.autrev.2014.12.004
35. Ito Y, Yoshida M, Sugiyama T, Masuda H, Mori M, Kimura N, et al. Multiple ulcerations and perforation in the small intestine after steroid treatment in eosinophilic granulomatosis with polyangiitis: A case report and literature review. Cardiovasc Pathol. 2020;47:107193. doi: 10.1016/j.carpath.2019.107193
36. Bagai S, Sharma A, Gupta R, Kumar V, Rathi M, Kohli HS, et al. Gastrointestinal involvement in granulomatosis with polyangiitis: Case report and review. Indian J Nephrol. 2019;29(6):415-418. doi: 10.4103/ijn.IJN_141_18
37. Ledó N, Pethő ÁG. Gastrointestinal symptoms as first remarkable signs of ANCA-associated granulomatosis with polyangiitis: A case report and reviews. BMC Gastroenterol. 2021;21(1):158. doi: 10.1186/s12876-021-01730-8
38. Kiboshi T, Isoda K, Furukawa K, Wakahara T, Otani K, Ueda K, et al. Granulomatosis with polyangiitis complicated with gastrointestinal perforation: A case report and review of literature. Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(5):382-386. doi: 10.2177/jsci.40.382
39. Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, et al. Sjögren’s syndrome: A systemic autoimmune disease. Clin Exp Med. 2022;22(1):9-25. doi: 10.1007/s10238-021-00728-6
40. Popov Y, Salomon-Escoto K. Gastrointestinal and hepatic disease in Sjogren syndrome. Rheum Dis Clin North Am. 2018;44(1):143-151. doi: 10.1016/j.rdc.2017.09.010
41. Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol. 2012;46(1):25-30. doi: 10.1097/MCG.0b013e3182329d9c
42. Mariette X. Lymphomas in patients with Sjögren’s syndrome: Review of the literature and physiopathologic hypothesis. Leuk Lymphoma. 1999;33(1-2):93-99. doi: 10.3109/10428199909093729
43. Pinnix CC, Reed V, Dabaja B. Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune disease. J Natl Compr Canc Netw. 2012;10(7):815-819. doi: 10.6004/jnccn.2012.0085
44. Kiesewetter B, Troch M, Müllauer L, Raderer M. Running in the family: MALT lymphoma and autoimmune disease in mother and daughter. World J Gastrointest Oncol. 2012;4(2):26-29. doi: 10.4251/wjgo.v4.i2.26
45. Ramos-Casals M, la Civita L, de Vita S, Solans R, Luppi M, Medina F, et al.; SS-HCV Study Group. Characterization of B cell lymphoma in patients with Sjögren’s syndrome and hepatitis C virus infection. Arthritis Rheum. 2007;57(1):161-170. doi: 10.1002/art.22476
46. Frittoli RB, Vivaldo JF, Costallat LTL, Appenzeller S. Gastrointestinal involvement in systemic lupus erythematosus: A systematic review. J Transl Autoimmun. 2021;4:100106. doi: 10.1016/j.jtauto.2021.100106
47. Brewer BN, Kamen DL. Gastrointestinal and hepatic disease in systemic lupus erythematosus. Rheum Dis Clin North Am. 2018;44(1):165-175. doi: 10.1016/j.rdc.2017.09.011
48. Zheng J, Ni R, Liu H. Intestinal pseudo-obstruction in systemic lupus erythematosus: An analysis of nationwide inpatient sample. Clin Rheumatol. 2022 Jul 11. doi: 10.1007/s10067-022-06283-z
49. Christiansen TK, Nilsson AC, Madsen GI, Voss A. Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case. Lupus. 2022;31(6):754-758. doi: 10.1177/09612033221093496
50. Rudiman R. Advances in gastrointestinal surgical endoscopy. Ann Med Surg (Lond). 2021;72:103041. doi: 10.1016/j.amsu.2021.103041
51. Rimola J, Torres J, Kumar S, Taylor SA, Kucharzik T. Recent advances in clinical practice: Advances in cross-sectional imaging in inflammatory bowel disease. Gut. 2022:gutjnl-2021-326562. doi: 10.1136/gutjnl-2021-326562
52. Christian M, Giovanni M, Torsten K, Mariangela A. Ultrasonography in inflammatory bowel disease – So far we are? United European Gastroenterol J. 2022;10(2):225-232. doi: 10.1002/ueg2.12196
53. Olson MC, Navin PJ, Welle CL, Goenka AH. Small bowel radiology. Curr Opin Gastroenterol. 2021;37(3):267-274. doi: 10.1097/MOG.0000000000000719
54. Delaney FT, Fenlon HM, Buckley B, Welaratne I, Cronin CG. Multimodality imaging of the gastrointestinal manifestations of scleroderma. Clin Radiol. 2021;76(9):640-649. doi: 10.1016/j.crad.2021.04.014
55. Enns RA, Hookey L, Armstrong D, Bernstein CN, Heitman SJ, Teshima C, et al. Clinical practice guidelines for the use of video capsule endoscopy. Gastroenterology. 2017;152(3):497-514. doi: 10.1053/j.gastro.2016.12.032
56. Marie I, Leroi AM, Menard JF, Levesque H, Quillard M, Ducrotte P. Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev. 2015;14(6):547-554. doi: 10.1016/j.autrev.2015.01.018
57. Nanke Y, Kotake S, Akama H, Tomii M, Kamatani N. Pancytopenia and colitis with Clostridium difficile in a rheumatoid arthritis patient taking methotrexate, antibiotics and non-steroidal antiinflammatory drugs. Clin Rheumatol. 2001;20(1):73-75. doi: 10.1007/pl00011187
58. Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Autoimmune gastritis: Pathologist’s viewpoint. World J Gastroenterol. 2015;21(42):12179-12189. doi: 10.3748/wjg.v21.i42.12179
59. Massironi S, Zilli A, Elvevi A, Invernizzi P. The changing face of chronic autoimmune atrophic gastritis: An updated comprehensive perspective. Autoimmun Rev. 2019;18(3):215-222. doi: 10.1016/j.autrev.2018.08.011
60. Singh P, Singh AD, Ahuja V, Makharia GK. Who to screen and how to screen for celiac disease. World J Gastroenterol. 2022;28(32):4493-4507. doi: 10.3748/wjg.v28.i32.4493
61. Iversen R, Sollid LM. The immunobiology and pathogenesis of celiac disease. Annu Rev Pathol. 2022 Sep 6. doi: 10.1146/annurev-pathmechdis-031521-032634
62. Koning F. Recent insight in the pathophysiology of coeliac disease: Relevance to rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(4 Suppl 92):8-10.
63. Poddighe D, Romano M, Dossybayeva K, Abdukhakimova D, Galiyeva D, Demirkaya E. Celiac disease in juvenile idiopathic arthritis and other pediatric rheumatic disorders. J Clin Med. 2022;11(4):1089. doi: 10.3390/jcm11041089
64. Orlando A, Renna S, Perricone G, Cottone M. Gastrointestinal lesions associated with spondyloarthropathies. World J Gastroenterol. 2009;15(20):2443-2448. doi: 10.3748/wjg.15.2443
65. Kucharz EJ, Kramza J, Grosicka A, Pieczyrak R. Clinical manifestations of Whipple’s disease mimicking rheumatic disorders. Reumatologia. 2021;59(2):104-110. doi: 10.5114/reum.2021.105418
66. Wang CR, Tsai HW. Autoimmune liver diseases in systemic rheumatic diseases. World J Gastroenterol. 2022;28(23):2527-2545. doi: 10.3748/wjg.v28.i23.2527
67. Kleinert S, Waldner M, Wendler J, Kunzmann V. Disease-modifying antirheumatic drugs in rheumatoid arthritis patients with a history of colorectal cancer. Z Rheumatol. 2016;75(1):41-46. doi: 10.1007/s00393-015-0032-8
68. Denaxas K, Ladas SD, Karamanolis GP. Evaluation and management of esophageal manifestations in systemic sclerosis. Ann Gastroenterol. 2018;31(2):165-170. doi: 10.20524/aog.2018.0228
69. Clarke K, Adler N, Agrawal D, Bhakta D, Sata SS, Singh S, et al. Indications for the use of proton pump inhibitors for stress ulcer prophylaxis and peptic ulcer bleeding in hospitalized patients. Am J Med. 2022;135(3):313-317. doi: 10.1016/j.amjmed.2021.09.010
70. Jaafar MH, Safi SZ, Tan MP, Rampal S, Mahadeva S. Efficacy of rebamipide in organic and functional dyspepsia: A systematic review and meta-analysis. Dig Dis Sci. 2018;63(5):1250-1260. doi: 10.1007/s10620-017-4871-9
71. Guevara B, Cogdill AG. Helicobacter pylori: A review of current diagnostic and management strategies. Dig Dis Sci. 2020;65(7):1917-1931. doi: 10.1007/s10620-020-06193-7
72. Veloso PM, Machado R, Nobre C. Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art. Eur J Pharm Biopharm. 2021;167:89-103. doi: 10.1016/j.ejpb.2021.07.014
73. Abraham B, Quigley EMM. Antibiotics and probiotics in inflammatory bowel disease: When to use them? Frontline Gastroenterol. 2020;11(1):62-69. doi: 10.1136/flgastro-2018-101057
74. Park YE, Cheon JH. Updated treatment strategies for intestinal Behçet’s disease. Korean J Intern Med. 2018;33(1):1-19. doi: 10.3904/kjim.2017.377
75. Beyer G, Habtezion A, Werner J, Lerch MM, Mayerle J. Chronic pancreatitis. Lancet. 2020;396(10249):499-512. doi: 10.1016/S0140-6736(20)31318-0
76. Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026. doi: 10.1038/nrdp.2018.26
77. Oksi J, Anttila VJ, Mattila E. Treatment of Clostridioides (Clostridium) difficile infection. Ann Med. 2020;52(1-2):12-20. doi: 10.1080/07853890.2019.1701703
Review
For citations:
Moroz E.V., Popkova T.V., Moroz A.E. Manifestations of the gastrointestinal tract in systemic rheumatic diseases: A narrative review. Rheumatology Science and Practice. 2022;60(6):578–586. (In Russ.) https://doi.org/10.47360/1995-4484-2022-578-586